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Anemia is accepted among critically ill patients as an alternative to elective blood trans-
fusion. This practice has been extrapolated to head injury patients with only one study 
comparing the effects of mild anemia on neurological outcome. There are no studies 
quantifying microcirculation during anemia. Experimental studies suggest that anemia 
leads to cerebral hypoxia and increased rates of infarction, but the lack of clinical equi-
poise, when testing the cerebral effects of transfusion among critically injured patients, 
supports the need of experimental studies. The aim of this study was to quantify cerebral 
microcirculation and the potential presence of axonal damage in an experimental model 
exposed to normovolaemic anemia, with the intention of describing possible limitations 
within management practices in critically ill patients. Under non-recovered anesthesia, 
six Merino sheep were instrumented using an intracardiac transeptal catheter to inject 
coded microspheres into the left atrium to ensure systemic and non-chaotic distribution. 
Cytometric analyses quantified cerebral microcirculation at specific regions of the brain. 
Amyloid precursor protein staining was used as an indicator of axonal damage. Animals 
were exposed to normovolaemic anemia by blood extractions from the indwelling 
arterial catheter with simultaneous fluid replacement through a venous central catheter. 
Simultaneous data recording from cerebral tissue oxygenation, intracranial pressure, and 
cardiac output was monitored. A regression model was used to examine the effects 
of anemia on microcirculation with a mixed model to control for repeated measures. 
Homogeneous and normal cerebral microcirculation with no evidence of axonal damage 
was present in all cerebral regions, with no temporal variability, concluding that acute 
normovolaemic anemia does not result in short-term effects on cerebral microcirculation 
in the ovine brain.
Keywords: anemia, aPP staining, histology, microcirculation, microspheres
February 2016 | Volume 7 | Article 62
Bellapart et al. Cerebral Blood Flow during Anaemia
Frontiers in Neurology | www.frontiersin.org
inTrODUcTiOn
Anemia and its pathophysiological implications have been 
investigated in recent years (1). The deleterious effects of blood 
transfusions have been well documented (2–4). Since the TRICC 
Trial (5), evidence based guidelines (6, 7) have influenced the 
use of blood transfusions, particularly in critically ill patients. 
However, a post hoc subgroup analysis of head injury patients from 
the TRICC trial (8) assessed the effects of restrictive transfusion 
strategies with hemoglobin concentrations maintained between 
7.0 and 9.0  g/dL compared to the maintenance of hemoglobin 
concentrations between 10.0 and 12.0  g/dL on neurological 
outcome at 60 days post-injury. In that study, the authors found a 
significantly higher incidence of blood transfusions in the liberal 
group, with no differences in the ICU or 60-day mortality, length 
of stay, or organ failures. However, the direct effects of anemia 
on neurological outcomes were not assessed. It is still contro-
versial whether anemia worsens brain injury (9–11). A recent 
study (12) examined the associations between the management 
of acute head injury patients with a restrictive versus a liberal 
transfusion threshold and the administration of erythropoietin 
with neurological outcomes at 6 months as the primary endpoint. 
No difference in neurological outcome was demonstrated with 
either intervention, with the lowest hemoglobin being 10 g/dL. 
However, several studies (13–18) have raised concerns regarding 
the safety of tolerating anemia in the setting of acute head injury. 
These studies showed that a sustained hemoglobin concentration 
of 7  g/dL correlated with secondary neurological injury from 
cerebral tissue hypoxia (13), with blood transfusion significantly 
increasing the partial pressure of cerebral tissue oxygenation 
(PTiO2) independently of cerebral perfusion pressure (14, 15). 
In addition, critical levels of PTiO2 (<15 mmHg) are correlated 
with a significant increase in the incidence of stroke and mortality 
(17–20). As a result of cerebral tissue ischemia, cerebral micro-
dialysis markers, such as lactate/pyruvate ratio, glutamate, and 
glycerol, rise as a reflection of altered cellular metabolism (21, 
22). In the absence of clinically available measures of cerebral 
microcirculation, transfusion thresholds in head injury patients 
may be better determined by physiological markers of cerebral 
ischemia and hypoperfusion rather than those recommended in 
more general critical care case mix where only mortality outcomes 
are assessed (22).
In light of this controversy, this novel study aimed to directly 
quantify regional microvascular blood flow (RMBF) using cyto-
metric counting of color-coded microspheres with the potential 
neurological injury assessed using amyloid precursor protein 
(APP) staining of brain tissue of sheep exposed to normovolemic 
anemia.
MaTerials anD MeThODs
animal care and Preparation
All experimental procedures were approved by the Animal Ethics 
Committee of the Queensland University of Technology and 
University of Queensland Committee and complied with local 
guidelines. Sheep were selected as the preferred animal model 
because of their cerebral anatomical similarities with humans, 
specifically within the gyrencephalic structure, allowing better 
examination of gray–white matter. In addition, the hemoglobin 
dissociation curve in sheep is comparable to that of human with 
a considerable amount of experimental studies in ovine neuro-
sciences. A triple lumen central line (Cook Medical INC., QLD, 
Australia) and two 16-Fr introducer sheaths were placed in the 
right internal jugular (RIJ) vein in a convenience sample of six 
Merino sheep wethers weighing 65 ± 6.01 kg. Via the central line, 
the sheep were placed under general anesthesia with an initial 
bolus of 5 mg/kg ketamine and a maintenance infusion between 
0.5 and 1 mg/kg/h. Sedation was achieved with a combined infu-
sion of midazolam (0.5 mg/kg/h), fentanyl (10 mcg/kg/h), and 
alfaxalone (6 mg/kg/h). This is a common veterinarian anesthetic 
regimen that has stable cardiovascular effects. Hydration was 
maintained with an infusion of Hartmann’s solution at a rate 
up to 2  mL/kg/h titrated to a central venous pressure (CVP) 
of 6–10  mmHg. Cardiovascular monitoring included cardiac 
output and vascular resistances via a Swan–Ganz catheter, as in 
previous models (23). A 5-Fr umbilical vessel catheter (Argyle, 
Tyco HealthCare, Mansfield, MA, USA) was placed in the right 
femoral artery to allow for blood withdrawal at a rate of 10 mL/
min. Orotracheal intubation was performed with a 10-mm 
endotracheal tube (SIMS Portex, UK). Sheep were ventilated at 
12 breaths per minute with tidal volumes of 8 mL/kg and 5 cm 
H2O of PEEP with an initial FiO2 of 1.0. The FiO2 and respiratory 
rate were titrated to maintain a partial pressure of oxygen (PaO2) 
of >95 mmHg and normocapnia. PEEP was maintained at 5 cm 
H2O to minimize de-recruitment and was not increased during 
the study, as this level of PEEP is known to have no effects on 
cerebral perfusion pressures (24). Neuromonitoring instrumen-
tation included a partial pressure of tissue oxygenation (PTiO2) 
probe (Licox, Oxford Optronics, Ltd, Oxford, UK) and an intrac-
ranial pressure (ICP) monitor, inserted via a mini-craniectomy 
at the left and right fronto-parietal regions, respectively. CPP 
was derived using the clinical algorithm: CPP = mean systemic 
arterial blood pressure (MAP)−ICP, with MAP being measured 
at the level of the heart.
To avoid self-transfusion from the ovine spleen (25, 26), a liga-
tion of the splenic artery was performed through a skin incision 
parallel to the distal end of the last rib on the left side followed 
by blunt dissection through the serratus and oblique abdominal 
muscles. The splenic artery and vein were identified, the artery 
ligated followed by injection of adrenaline (0.025 mL of 1:10,000 
dilutions) directly into the spleen parenchyma and a 60-s wait-
ing period to allow for spleen contraction and the return of the 
sequestered blood into the systemic circulation.
normovolaemic anemia Model
Acute normovolaemic anemia was achieved by sequential blood 
extractions from the indwelling arterial catheter performed 
simultaneously with isovolaemic saline infusions. The aim was 
to achieve a 30% reduction of baseline hemoglobin to reproduce 
the fall in hemoglobin concentration that was achieved in the 
TRICC trial. The targeted hemoglobin was monitored using 
cardiac index, blood pressure, systemic vascular resistances, and 
arterial blood gas sampling to ensure stable and normal lactate 
levels, every 15 min.
FigUre 1 | (a) Cone post-mortem and post-fixation samples representing 
the anatomical regions of interest. AL, left parietal; BL, left temporal; C, 
left-sided basal ganglia; AR, right parietal; BR, right temporal, D, Medulla. (B) 
Post-mortem spleen showing macroscopic evidence of infarct as a result of 
successful splenic artery ligation.
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Protocol for Transeptal catheterization 
and injection of Microspheres
Following anesthesia, a transeptal catheter was inserted into the 
left atrium (LA) under intracardiac echocardiography (ICE) sur-
veillance. Two 11-Fr Terumo sheaths located in the RIJ allowed 
for the insertion of the intracardiac ultrasound probe (Acuson 
AcuNav™ probe, California®) and the transeptal catheter 
(Mullins TS introducer, Medtronic®). Echocardiography images 
were obtained using an Acuson Sequoia C512 scanner (Siemens, 
CA, USA). Transeptal puncture and insertion of a pigtail catheter 
into the LA followed previously described methods (27).
Protocol for Microsphere injection
Randomly assigned color-coded microspheres (E-Z TRAC; 
Interactive Medical Technology, Los Angeles, CA, USA) were 
injected hourly via the LA pigtail catheter using the following 
protocol. Six different colors (purple low, purple high, pink high, 
yellow high, coral low, and coral high) were used as per the manu-
facturer’s recommendations. For each injection, a thoroughly 
mixed vial of one color of microspheres containing 5 million 
spheres in 0.8 mL volume was used. This microsphere density is 
recommended by the manufacturer and does not cause microvas-
cular plugging or occlusion (23). At 30 s following the initiation 
of the blood withdrawal with a pump rate of 10 mL/min, a fast 
injection of the microspheres followed by a 10 mL saline flush 
over 10 s was performed. The withdrawal pump was turned off 
after 2 min of use, and Tween 80 reagent was used to clear the 
arterial catheter and dilute the microspheres.
aspects of the injection of color-coded 
Microspheres
Approximately, five million color-coded spheres of one color 
were injected at each hour with the color of the microspheres 
randomly assigned at each injection time, to minimize selection 
biases and to enable the quantification of flow at each defined 
time points. Each sheep had a different microsphere color injected 
at defined time points to assess temporal changes in RMBF by 
anatomical area. As per the manufacturer’s recommendations, 
the microspheres were maintained at room temperature, were not 
exposed to sunlight, heat, or vibration, and were mixed manually 
to minimize foaming and avoid non-uniform concentrations of 
microspheres throughout each injection.
euthanasia and Post-Mortem Tissue 
Manipulation
After 5 h of continuous monitoring and microsphere injection, 
sheep were euthanized under non-recovered anesthesia with a 
bolus injection of 0.5  mL/kg of sodium pentobarbitone. After 
confirmation of death, the brain was harvested by craniotomy, 
weighed, and then fixed in 10% formalin for 3 weeks.
Brain harvesting Technique
Brains were harvested using a deep incision of the skin and under-
lying tissue planes between the first and second occipital vertebral 
body with the intention of sectioning the spinal cord at that level. 
A round reciprocating saw was used to create a wide bitemporal 
bone incision. Rectangular bone sections of ~5 cm were made 
anteriorly to the bitemporal incision to the frontal sinuses. These 
bone sections were removed with retractors with simultaneous 
dissection of the dura. Once the brain was fully exposed, the 
olfactory bulbs, optic chiasm, tentorium, and cranial nerves 
were sectioned to liberate the brain from the cranium.
Tissue sampling Model
A novel design for tissue sampling was developed to capture the 
specific anatomical regions of interest (Figure 1A). After creat-
ing 5-mm brain blocks, 0.4 g cone samples were extracted from 
the hemispheres (AR corresponding to right parietal cortex, BR 
corresponding to right temporal cortex, AL corresponding to left 
parietal cortex, and BL corresponding to left temporal cortex), 
basal ganglia (C), and medulla (D). Adjacent tissue blocks were 
assigned for both cytometric and histological analyzes. This novel 
design allowed us to directly quantify axonal damage and RMBF 
in specific anatomical regions, which could be compared between 
subjects with different brain sizes.
Samples of skin, gut, kidney, spleen, and heart were harvested 
to demonstrate the systemic distribution of the microspheres. The 
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spleen was sampled to demonstrate splenic infarct due to suc-
cessful arterial spleen ligation and the absence of microspheres 
(Figure 1B).
Quantification of Microvascular  
Blood Flow
Cytometric counts of the microspheres were performed using 
a validated technique (23, 28–30). Cytometric count of micro-
spheres allows the calculation of RMBF in each particular 
organ through a process that includes the specific microspheres 
concentration injected into the systemic circulation at each time 
point and the amount of spheres in a reference sample of arterial 
blood, known also as the “reference sample of blood”, extracted 
also at each time point. The reference sample was an arterial 
blood sample withdrawn at a known rate over a fixed period of 
time (31). RMBF was the proportion of microspheres trapped in 
the targeted tissue in relation to the total quantity of spheres per 
milliliter of blood per minute of the reference sample and was 
calculated using the following algorithm (32):
 
RMBF mL g Total tissue spheres
Tissue weight g
f
/min/ /
,
Re
( ) = ( )
( ) ×
erence Spheres mL/ /min( )  
This cytometric analysis was performed at Interactive Medical 
Technology (IMT), Los Angeles, CA, USA.
immunohistochemistry Processing
Immunohistochemistry analysis was performed at the neuropa-
thology laboratory, Royal Brisbane and Women’s Hospital, QLD, 
Australia, using a Leica Novolink Polymer Detection Systems Kit 
(Leica Microsystems Pty Ltd., North Ryde, 2113 Australia) as per 
the manufacturer’s instructions. Paraffin was removed from the 
sections through a series of xylene immersions and re-hydrations. 
Antigen retrieval was carried out using Leica BOND ER1 solu-
tion. Endogenous peroxidase was neutralized. Sections were 
incubated with a protein block. The primary antiserum made up 
in Leica BOND Antibody Diluent was applied to the sections.
immunohistochemistry and  
hematoxylin–eosin scoring and 
interpretation
Immunohistochemistry analysis was applied to the sheep brains 
for the baseline presence and location of APP antibodies. APP 
antibody staining was used because it is considered to be a very 
early marker of neuronal damage (33) and this study had a short 
follow-up period (4 h post intervention). A grading system meas-
uring the presence of APP was developed and structured into 
three qualitative categories dependent on the severity of injury: 
Mild Injury: focal contusion with APP labeling limited to the site 
of the injury or focal APP labeling; Moderate Injury: a pattern of 
APP staining greater than one hemisphere, greater than half a 
hemisphere, or less than half a hemisphere; and Severe Injury: the 
presence of diffuse staining sub-classified as either diffuse vascu-
lar injury, diffuse axonal injury with macroscopic hemorrhage, 
diffuse axonal injury with microscopic hemorrhage/tissue tears, 
or diffuse axonal injury only (34). For each animal, samples were 
taken from each brain anatomical region of interest for both 
cytometric counts of RMBF and immunohistochemistry.
statistical analysis
RMBF Analysis
Regional microvascular blood flow was measured at baseline 
with no anemia (corresponding to time zero – T0) and at four 
follow-up times following the induction of anemia (T1–T4 
corresponding to first to the fourth hour post intervention). A 
repeated-measure mixed regression model was used to examine 
differences in RMBF associated with anemia, and a mixed model 
with a random intercept was used for each sheep to control for 
repeated results from the same sheep.
To examine the variability in RMBF, all results were plot-
ted using box-plots. We also calculated the percentage of the 
total variation in the mixed models due to the between-sheep 
 variability. A high percentage (above 50%) indicated that 
the variance in RMBF was due to differences between sheep, 
whereas a lower percentage indicated that the differences 
between sheep were small. The analysis was performed used R 
software version 3.0.2.
resUlTs
Despite a fall in hemoglobin to levels between 6 and 7 g/dL (a 30% 
of the baseline hemoglobin in each animal) with normovolaemia, 
cerebral RMBF throughout all anatomical areas of interest was 
maintained in a physiological range after correction to conven-
tional units (mL/100  g/min) during the 4  h of studying time. 
However, subject number 3 had a significant increase in RMBF 
at 4 h (T4) with otherwise similar RMBF values at earlier time 
points (Figure 2A). This was due to the reference blood sample 
containing significantly fewer microspheres due to a most likely, 
defective withdrawal pump rate, leading to an overestimation of 
RMBF.
Box-plots (Figure 2B) show changes in RMBF variability over 
time. The heights of the boxes and their means are similar, sug-
gesting that the values were maintained within similar ranges. 
The dots indicate the presence of some outliers.
The effect of anemia on RMBF during the 4 h of study time 
is presented in Table  1. Anemia decreased the RMBF in the 
kidneys. The highest ratio of 97% was observed in the skin. The 
between-sheep variability seen in Figures 2A,B depended mainly 
on the outlier values of subject 6.
The cardiovascular responses to acute normovolaemic anemia 
are presented in Table 2. For the majority of animals, the physi-
ological response to acute anemia was a reduction in cardiac out-
put and an increase in the systemic vascular resistances. Vascular 
resistances were not available for subject 1 due to a calibration 
error.
The cerebral PTiO2, CPP, and CO responses to acute anemia 
are described in Table 2. For the majority of subjects, temporal 
reductions in cerebral perfusion pressure and cerebral PTiO2 
were observed during anemia. Despite these changes in regional 
FigUre 2 | (a) Representation of the regional blood flow for each subject over time at each particular region of interest and other extra-cranial tissues. Time is 
represented as T0 (baseline time or time prior to intervention); T1 (first hour post intervention); T2 (second hour post intervention); T3 (third hour post intervention), 
and T4 (fourth hour post intervention). (B) RMBF means at each time point of all subjects, showing stable, homogeneous, and sustained RMBF during anemia. Time 
is represented as T0 (baseline time or time prior to intervention); T1 (first hour post intervention); T2 (second hour post intervention); T3 (third hour post intervention); 
and T4 (fourth hour post intervention).
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cerebral oxygenation, both histology and immunohistochemis-
try were consistent with normal neural tissue, represented by 
a normal hematoxylin–eosin and APP staining, respectively 
(Table  3), with only isolated areas of petechial hemorrhage 
(Figure 3).
DiscUssiOn
This study demonstrates the maintenance of stable cerebral 
microcirculation in Merino sheep during and after 4  h of sus-
tained normovolaemic anemia. After the achievement of a 
TaBle 1 | effect of anemia on rMBF by anatomical regions.
Tissue Mean lower Upper p-value ratio
AI 0.045 −0.166 0.256 0.676 7
BI 0.053 −0.150 0.258 0.609 19
AR 0.075 −0.203 0.354 0.6 3
BR 0.067 −0.186 0.322 0.601 29
C 0.050 −0.148 0.247 0.619 28
D 0.077 −0.221 0.375 0.613 11
Slice 0.082 −0.189 0.353 0.553 26
Skin −0.042 −0.101 0.016 0.164 97
Spleen 0.000 −0.001 0.001 0.989 42
Kidney −1.371 −2.505 −0.229 0.0248 30
Heart 0.089 −0.508 0.690 0.769 17
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30% reduction of baseline hemoglobin, as in the TRICC trial, 
despite a reduction in cardiac output and an increase in vascular 
resistances, RMBF remained unchanged in both intra- and inter-
subject comparisons. This observation suggests that despite the 
cardiovascular impact of anemia, cerebral autoregulation in an 
otherwise intact brain is perhaps the mechanism involved in the 
preservation of microcirculation throughout different anatomical 
regions; however, specific measurement of cerebral autoregula-
tion was not the focus of this study.
Normovolaemic anemia alone in the short term does not 
appear to have objective effect on brain tissue histo-anatomy. 
However, cerebral microcirculation and cerebral autoregulation 
TaBle 2 | cardiovascular and cerebral oximetry response to normovolemic anemia.
hours post 
intervention
T 0 goal:  
reduction of 30% 
baseline hbl
T1 T2 T3 T4
Baseline time First hour post 
intervention
second hour post 
intervention
Third hour post 
intervention
Fourth hour post 
intervention
sheeP 1
CO (L) 4.8 4.1 2.7 2.5 2.5
SV02 (%) 75 71 46 55 50
SVR (dynes s/cm/m2)
Hbl (g/dL) 12.8 10.0 7.6 7.8 8.1
CPP 100 80 70 65 65
PTiO2 17.3 8.2 10 5.4 6.1
sheeP 3
CO 5 4.5 3.6 3.6 3.7
SV02 (%) 85 75 71 75 76
SVR (dynes s/cm/m2) 1445 1682 1865 1817 1886
Hbl 12.4 7.8 8.1 8.1 8.1
CPP 90 84 84 75 83
PTiO2 2.65 2.89 3.26 4.90 5.21
sheeP 4
CO 4.3 4.0 4.7 4.2 4.3
SV02 (%) 66 70 69 67 67
SVR (dynes s/cm/m2) 1250 1060 1240 1270 1280
Hbl 10.3 7.9 8.1 7.9 7.9
CPP 122 118 118 107 106
PTiO2 25 43 45 42 44
sheeP 5
CO 4.1 3.9 3.2 2.7 3.2
SV02 (%) 62 62 55 49 56
SVR (dynes s/cm/m2) 2245 2258 2460 2622 2367
Hbl 9.7 7.5 6.9 7.1 7.0
CPP 109 110 93 100 80
PTiO2 26 16 12 13.6 14.1
sheeP 6
CO 3.4 3.3 3.7 3.0 3.8
SV02 (%) 77 72 66 66 71
SVR (dynes s/cm/m2) 2226 2133 1678 1601 1228
Hbl 11.0 6.7 7.5 7.5 7.0
CPP 100 82 93 92 92
PTiO2 5.7 2.15 2 1.8 2.1
sheeP 7
CO 4.0 2.6 3.3 3.9 3.8
SV02 (%) 83 70 71 75 75
SVR (dynes s/cm/m2) 1490 3196 2064 1694 1682
Hbl 10.9 7.9 7.5 7.5 7.2
CPP 99 98 90 85 85
PTiO2 37 5.8 9.5 10.2 7.4
Bold values represent the baseline hemoglobin as a way to magnify the successful achievement of anaemia maintained in the following cut off time-points.
TaBle 3 | aPP staining score for all anatomical regions of interest and 
subjects.
subject 
number
region of 
interest
h&e staining aPP 
staining
Sheep 01 AL Normal 0
AR Normal 1
BL Normal 0
BR Microglial activation 2
C Focal hemorrhagic necrosis 2
D Normal 0
Sheep 03 AL Normal 0
AR Normal 0
BL Normal 0
BR Normal 0
C Normal 0
D Small perivascular petechial 
hemorrhage
1
Sheep 04 AL Normal 0
AR Normal 0
BL Normal 0
BR Small perivascular petechial 
hemorrhage at edge, artifact?
0
C Small perivascular petechial 
hemorrhage at edge, artifact?
0
D Normal 0
Sheep 05 AL Normal 0
AR Normal 0
BL Normal 0
BR Normal 0.5
C Normal 0
D Normal 0
Sheep 06 AL Localized focus of acute meningitis 
and SAH in depth of sulcus
0
AR Normal 0
BL Normal 0
BR Normal 0
C Focal hemorrhage near deep gray nuclei 2
D Normal 0
Sheep 07 AL Normal 0
AR Normal 0
BL Normal 0
BR Normal 0
C Normal 0
D Normal 0
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have heterogeneous behaviors that can lead to perfusion 
mismatch. This characteristic may be magnified in  situations 
where normal perfusion is compromised, such as in head injury 
and hemorrhagic shock (35, 36) or in pre-morbid conditions 
affecting the cardiovascular physiology, such as hypertension, 
vascular diseases, or diabetes. Brain blood flow varies according 
to the anatomical regional (37) and it remains unclear if this 
represents a phylogenic remnant or a response to metabolic 
demands. While many factors have been considered to influ-
ence microcirculation (38), the optimal level of hemoglobin 
during acute head injury remains controversial. In this study, 
we demonstrate that during acute normovolaemic anemia to 
levels of hemoglobin of 6  g/dL, RMBF remains normal and 
unchanged over 4 h. The results of our study are in concordance 
with the most recent study (12) in acute head injury patients; 
however, that study was compromised by the concomitant use 
of erythropoietin and a small sample size.
The experimental strategy used for the direct measurement of 
RBMF and tissue sampling in this study has proven to be feasible. 
Quantification of RMBF in specific brain regions allows for intra- 
and inter-subject comparisons and is a significant improvement 
on previous approaches using predefined brain thickness section-
ing (27). In this study, RMBF in the specific regions of interest 
shared the same values when a predefined brain slicing technique 
was used. In addition, with both strategies, RMBF values were 
within normal ranges.
Limitations of this study are inherent to the experimental nature 
of the study. Regional microcirculatory blood flow cytometric 
count in targeted regions of the brain, before and after an insult 
is not a feasible method in humans. Cerebral cytometric count 
of microspheres is mainly an experimental concept although it 
shares the same physical principle of flow cytometry extensively 
applied in diagnostic medicine (39). Another limitation of this 
study refers to the short study time; however, the primary inten-
tion of this study design was to focus on the direct effect of acute 
normovolemic anemia in cerebral RMBF at specific anatomical 
regions of interest, not the long-term effects of anemia in cerebral 
physiology, let alone neurological outcomes. Finally, this study 
was applied in healthy subjects as the investigators intended to 
exclude all possible confounders to the direct effect of short-term 
anemia in cerebral microcirculatory dynamics. It is plausible 
to presuppose that the same degree of anaemia in pre-morbid 
subjects could have led to different RMBF distribution; however, 
this was not the main aim of the study; but to establish the direct 
effect of anemia in cerebral microcirculation as a preliminary 
model to compare with future head injury models.
This study achieved predefined aims and followed a rigorous 
methodology, demonstrating that short-term normovolemic 
anemia does not impair cerebral RMBF at specific anatomical 
regions, a model not feasible in the clinical arena, as an adjunct 
data to future head injury studies.
FigUre 3 | Petechial hemorrhage with minimal hematoxylin–eosin 
and aPP staining seen in a cerebral tissue sample.
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